Nouvelle déclaration d'incident
No de la demande: 2011-1835
Numéro de référence du titulaire d'homologation: PROSAR Case#: 1-25496880
Nom du titulaire (nom légal complet, aucune abbréviation): Syngenta Crop Protection Canada, Inc.
Adresse: 140 Research Lane, Research Park
Ville: Guelph
État: Ontario
Pays: Canada
Code postal /Zip: N1G4Z3
Incident chez l'humain
Pays: CANADA
État: ONTARIO
Inconnu
ARLA No d'homologation 27428 ARLA No de la demande d'homologation EPA No d'homologation.
Nom du produit: Demand CS Insecticide
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. Inconnu
Nom du produit: Tempo
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. Inconnu
Nom du produit: Prelude
Inconnu
Inconnu
Personne affectée
Sexe: Homme
Âge: >19 <=64 yrs / >19 <=64 ans
Système
>2 mos and <=6mos />2 mois et <=6mois
Oui
Inconnu
Professionnel
Application
Inconnu
Peau
Respiratoire
Unknown / Inconnu
Unknown / Inconnu
1-25496880- The reporter calls to indicate possible exposure to an insecticidal product containing the active ingredient lambda-cyhalothrin. The caller also indicated he has historically worked with vaguely identified products which contained the active ingredients cyfluthrin and permethrin. The caller indicated he has worked as a pest control operator for some time (nonspecific duration). He indicates during the past two seasons he has worked with the three products but has not used personal protective equipment. He indicates possible dermal and inhalation exposure, but does not indicate a discreet incident exposure. He reports within the past three months he has developed tinnitus hearing sensitivity, headache and dizziness. He reports within the past two months twitching in his lower legs and ach weakness in his thighs. Intermittently within the past three months the caller report his vision has got out of balance which he clarifies as blurriness or delayed focusing of his eyes. He has gotten corrective lenses which he has reported has helped. The reporter indicates he has been to his general practitioner which has diagnosed an ear infection and placed him on two separate courses of antibiotics. His symptoms have not resolved. The reporter indicates he has been to two specialists (nonspecific) who have reported his hearing and ears are normal. He reports he has had two MRIs which were not diagnostic. His general practitioner has released him from work for the past month, but he states the symptoms have not improved. The reporter has indicated he is currently being referred to a toxicologist and an otolaryngologist. These appointments are pending. The caller was advised of the typical symptoms seen following dermal and inhalation exposure these active ingredients. It was recommended he continue to work with his physician to determine the cause of his current symptoms. The symptoms described are inconsistent with the toxicity profile of the listed active ingredients. Update was obtained from the caller two weeks following his initial contact with the registrant. He reports he has been to a neurologist. His primary care physician had suggested he may have carpal tunnel syndrome. The neurologist stated he did not have carpal tunnel syndrome and reached no diagnosis. The caller stated he was told there was nothing that could be done for him by this doctor. He has been to two otolaryngologists since his initial contact for the symptom of tinnitus. The first detected minor hearing loss and no structural abnormalities. He was referred to a second otolaryngologist for studies of his inner ear which, he reported, showed no abnormalities. He reports he was given one prescription (unspecified) by his family doctor for the tinnitus which did not alleviate that symptom. Current symptoms, when asked, included: ringing in ears, sick feeling in head and twitching in legs when at rest. He reports he has been on work release for one and one half month. When asked about follow up appointments or plans for his care he could provide no plan. He indicated his family doctor had wanted him to see a toxicologist at one point but he had no current appointment. He reports his family doctor indicated his chief rule outs included chemical exposure (nonspecific) and viral. The caller was advised the symptoms and time line indicated were inconsistent with the toxicity profile of the product. He was urged to continue to follow with his health care provider to determine the etiology of his current illness and most appropriate therapy. No further information is available.
Modérée
This Incident Report is being filed based on PMRAs current interpretation of the Incident Reporting Regulations. There is no direct evidence of exposure; the subject cannot describe a discrete exposure event. The symptoms described are not consistent with exposure to any of the active ingredients involved. Follow-up with the patient indicates he is suffering from a series of signs and symptoms that are inconsistent with exposure to a pyrethroid insecticide.